Study: Children with vision impairment have reduced quality of life

News
Article

Research from Orbis International analyses the overall wellbeing of children with common childhood vision problems

A child wearing glasses sits in a classroom among her peers who do not have glasses. Image credit: ©Drazen – stock.adobe.com

Orbis noted the impact of vision impairment on quality life and mental health. Image credit: ©Drazen – stock.adobe.com

Orbis International has released results of a study1 that found children with myopia and strabismus often experienced significantly reduced quality of life compared to those without vision impairment.

Published in Ophthalmology, the study also finds that surgical treatment of strabismus improves quality of life among children, underscoring the importance of early detection, treatment and health insurance coverage of strabismus for children.

According to a news release, the research received financial support from Santen, and the study is the first systematic review and meta-analysis of the links between quality of life in children and vision impairment, ocular morbidities and their treatment.

Moreover, Orbis noted in its release quality of life and mental health are increasingly being recognised as important global health concerns. With an estimated 70 million children experiencing vision impairment around the world, understanding the impact of these conditions on mental health is critical.1

The company noted that a child's vision function is assessed by clarity or sharpness of their vision. However, this approach does not measure a child's perception of their own visual impairment and ability to successfully complete daily tasks. For example, chronic eye conditions that may not affect central vision but have other negative impacts, like strabismus, have been shown to cause physical, educational and socioemotional difficulties in their daily lives.

This study is a companion research study2 published last year by Orbis, and also published in Ophthalmology, that found children with myopia and strabismus were diagnosed with higher rates of depression and anxiety than children without vision impairment.

"Our papers in Ophthalmology furnish the strongest evidence yet that impaired vision in children is associated with mental health problems, such as depression and anxiety," Prof Nathan Congdon, director of Research at Orbis International, said in the news release. "This latest study provides an even broader picture of a child's mental health, including quality of life, wellbeing, and self-esteem, meaning we now have a complete story about how a lack of vision care can cause mental health problems for a child."

Reference:

  1. Dongfeng LI, Ving Fai Chan, PhD, Gianni Virgili, PhD, et.al. Impact of Vision Impairment and Ocular Morbidity and Their Treatment on Quality of Life in Children: A Systemic Review.Ophthalmology. Published September 9, 2023. Accessed September 14, 2023. DOI: 10.1016/j.ophtha.2023.09.005.
  2. Dongfeng Li, Ving Fai Chan, PhD, Gianni Virgili, PhD. Impact of Vision Impairment and Ocular Morbidity and Their Treatment on Depression and Anxiety in Children. Ophthalmology. Published October 2022. Accessed September 14, 2023. DOI: 10.1016/j.ophtha.2022.05.020.
Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.